246 related articles for article (PubMed ID: 7589767)
1. Antihypertensive efficacy and safe use of once-daily sustained-release diltiazem in the elderly: a comparison with captopril. The Dilcacomp Study Group.
Nicaise J; Neveux E; Blondin P
J Int Med Res; 1995; 23(4):244-53. PubMed ID: 7589767
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of diltiazem sustained-release and captopril on blood pressure control and plasma lipoproteins in primary hypertension: a randomized, double-blind, crossover study.
Lacourcière Y; Poirier L; Boucher S; Spenard J
J Hum Hypertens; 1990 Oct; 4(5):553-6. PubMed ID: 2283645
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind comparison of the antihypertensive efficacy and safety of once-daily losartan compared to twice-daily captopril in mild to moderate essential hypertension.
Roca-Cusachs A; Oigman W; Lepe L; Cifkova R; Karpov YA; Harron DW
Acta Cardiol; 1997; 52(6):495-506. PubMed ID: 9542575
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with a once-daily, extended-release formulation of diltiazem in the treatment of hypertension.
Graney WF
Am J Med; 1992 Aug; 93(2A):56S-64S. PubMed ID: 1519637
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive efficacy of optimally titrated doses of once-daily sustained-release diltiazem: a placebo-controlled trial. DILPLACOMP Study Group.
Ollivier JP; Wajman A; Stalla-Bourdillon A
Cardiology; 1995; 86(6):481-7. PubMed ID: 7585759
[TBL] [Abstract][Full Text] [Related]
6. Diltiazem and captopril alone or in combination for treatment of mild to moderate systemic hypertension.
Wolfson P; Abernethy D; DiPette DJ; Zusman R
Am J Cardiol; 1988 Oct; 62(11):103G-108G. PubMed ID: 3051990
[TBL] [Abstract][Full Text] [Related]
7. Multicenter evaluation of the efficacy and safety of sustained-release diltiazem hydrochloride for the treatment of hypertension.
Woehler TR; Eff J; Graney W; Heald D; Ziemniak J; Magner D
Clin Ther; 1992; 14(2):148-57. PubMed ID: 1611639
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of the efficacy and tolerability of sustained-release verapamil and captopril in mild to moderate essential arterial hypertension].
Maarek-Charbit M; Stephan D; Welsch M; Galey-Arcangioli C; Imbs JL
Ann Cardiol Angeiol (Paris); 1991 Oct; 40(8):509-13. PubMed ID: 1759789
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerance of sustained-release diltiazem 300 mg and a diuretic in the elderly.
Djian J; Roy M; Forette B; Lekieffre J; Luccioni R
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S51-5. PubMed ID: 1706015
[TBL] [Abstract][Full Text] [Related]
10. Once daily perindopril versus slow release diltiazem in the treatment of mild to moderate essential hypertension. Canadian Study Group on Perindopril.
Can J Cardiol; 1994 Nov; 10 Suppl D():8D-12D. PubMed ID: 7954041
[TBL] [Abstract][Full Text] [Related]
11. Once daily compared with twice daily administration of slow-release diltiazem as monotherapy for hypertension.
Nikkilä M; Inkovaara J; Heikkinen J
Ann Med; 1991 Apr; 23(2):141-5. PubMed ID: 2069791
[TBL] [Abstract][Full Text] [Related]
12. Comparative study on monotherapy with sustained-release diltiazem 300 mg and enalapril 20 mg in mild to moderate arterial hypertension.
Fermé I; Djian J; Tcherdakoff P
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S46-50. PubMed ID: 1706014
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive efficacy and tolerability of once-daily sustained-release diltiazem alone and in combination with ramipril in hypertension.
Tuteja R; Swarup D; Saxena GN; Bhandari S; Sharma P
J Assoc Physicians India; 1999 Oct; 47(10):962-5. PubMed ID: 10778687
[TBL] [Abstract][Full Text] [Related]
14. Sustained antihypertensive activity of diltiazem SR: double-blind, placebo-controlled study with 24-hour ambulatory blood pressure monitoring.
Whelton A; Eff J; Magner DJ
J Clin Pharmacol; 1992 Sep; 32(9):808-15. PubMed ID: 1430300
[TBL] [Abstract][Full Text] [Related]
15. Effects of sustained-release diltiazem on blood pressure and serum lipids: a multicenter, randomized, placebo-controlled study.
Djian J; Fermé I; Zannad F; Chaignon M; Asmar R
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S38-45. PubMed ID: 1706012
[TBL] [Abstract][Full Text] [Related]
16. Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension.
Frishman WH; Zawada ET; Smith LK; Sowers J; Swartz SL; Kirkendall W; Lunn J; McCarron D; Moser M; Schnaper H
Am J Cardiol; 1987 Mar; 59(6):615-23. PubMed ID: 3548301
[TBL] [Abstract][Full Text] [Related]
17. 24-hour efficacy of once-daily diltiazem in essential hypertension.
Massie BM; Der E; Herman TS; Topolski P; Park GD; Stewart WH
Clin Cardiol; 1992 May; 15(5):365-8. PubMed ID: 1623657
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure control with diltiazem XR, a novel extended-release formulation of diltiazem HCl, in mature and elderly hypertensive patients.
Fiddes R; Heym H; Hilty W; Lewin AJ; Codispoti J; McNally C; Stokes A; Gilderman L
Clin Ther; 1994; 16(2):209-21. PubMed ID: 8062317
[TBL] [Abstract][Full Text] [Related]
19. Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertension.
Lueg MC; Herron J; Zellner S
Clin Ther; 1991; 13(4):471-81. PubMed ID: 1933999
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension. The Eprosartan Multinational Study Group.
Hedner T; Himmelmann A
J Hypertens; 1999 Jan; 17(1):129-36. PubMed ID: 10100104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
